Altair Therapeutics Announces Commencement of a Multi-Center Phase IIa Clinical Trial of Inhaled AIR645 to Treat Asthma
11/19/2009 8:34:54 AM
More...
|
Altair Therapeutics Secures $17 Million Financing
11/11/2009 1:36:59 PM
More...
|
Altair Therapeutics Reports Successful Phase I Study of Inhaled AIR645
9/14/2009 9:07:36 AM
More...
|
Altair Therapeutics Reports Successful Completion of Phase I Study of Inhaled AIR645
5/18/2009 8:30:54 AM
More...
|
Altair Therapeutics Appoints Dr. Joel Martin President and CEO
5/14/2009 11:04:07 AM
More...
|
Forward Ventures Joins Series A Syndicate for Newly Formed Altair Therapeutics
12/18/2007 11:30:43 AM
More...
|
Isis Pharmaceuticals, Inc. (ISIS) and Thomas, McNerney & Partners Announce Plans for Newly Formed Altair Therapeutics
10/16/2007 10:15:00 AM
More...
|